Lymphoma

1.    Schwarzmeier JD et al. Regulation of CD23 expression by Notch2 in B-cell chronic lymphocytic leukemia. Leuk Lymphoma 2005;46:157-65.
2.    Barna G et al. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Hematol Oncol 2008;26:167-70.
3.    Ranheim EA eta l. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells. Blood 1995;12:3556-65.
4.    Widney D et al. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma. Ckin Immunol 1999;93:114-23.
5.    Lens SM. Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol 1998;10:491-9.
6.    Schneider C et al. Pleiotropic signal transduction mediated by human CD30: a member of the tumor necrosis factor receptor (TNFR) family. Leuk Lymphoma 2002; 43:1355-66.
7.    Ko YH et al. Granzyme B leakage-induced apoptosis is a crucial mechanism of cell death in nasal-type NK/T-cell lymphoma. Lab Invest 2007;87:241-50.
8.    Kim GE et al. The significance of granzyme B expression in patients with angiocentric lymphoma of the head and neck. Cancer 2001;91:2343-52.
9.    Goto N et al. Serum-soluble tumor necrosis factor receptor 2 (sTNF-R2) level determines clinical outcome in patients with aggressive non-Hodgkin's lymphoma. Eur J Haematol 2006;77:217-25.
10.    Kalmanti M et al. Serum levels of tumor necrosis factor and soluble interleukin 2 receptor as markers of disease activity and prognosis in childhood leukemia and lymphoma. Int J Hematol 1993;57:147-52.